Join
Live feed
·
INSIDERFilingvia Quantisnow
Aquestive Therapeutics Inc. logo

Chief Development Officer Davis Matthew W. was granted 50,000 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
AQST· Aquestive Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AQST (Aquestive Therapeutics Inc.) and more on Quantisnow.